Once sidelined, Eli Lilly’s COVID-19 antibody treatment is on the comeback trail with new $1.3B supply agreement
TrustVaccines
via FiercePharma: Vaccines https://ift.tt/2zKtXvv
November 2, 2021 at 11:56AM
Once sidelined, Eli Lilly’s COVID-19 antibody treatment is on the comeback trail with new $1.3B supply agreement
Welcome to vaccine education 